SCHEMBL4564716

SCHEMBL4564716

CN(C)CCn1ccc(C(N)=O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 1/20 0.41
KDM5B Q9UGL1 1/20 0.41
HTR2C P28335 3/20 0.37
HTR1A P08908 1/20 0.37
HTR1D P28221 1/20 0.37
AKR1B1 P15121 1/20 0.36
CNR1 P21554 1/20 0.35
RET P07949 1/20 0.34
PHLPP2 Q6ZVD8 1/20 0.34
FGFR3 P22607 1/20 0.33
ALDH1A1 P00352 2/20 0.33
CNR2 P34972 1/20 0.33
CYP1A2 P05177 1/20 0.33
POLB P06746 1/20 0.33
KDM1A O60341 1/20 0.33
KDM4E B2RXH2 1/20 0.33
BRD4 O60885 1/20 0.33
BRPF1 P55201 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20515231 0.81 AKR1B1 (0.39) AKR1B1CNR1ALDH1A1POLBKDM4E
SCHEMBL31701380 0.79 CA12 (0.47) AKR1B1CNR1ALDH1A1POLBKDM4E
SCHEMBL30098901 0.77 AKR1B1 (0.39) AKR1B1CNR1ALDH1A1POLBKDM4E
SCHEMBL4553409 0.77 AKR1B1 (0.41) AKR1B1CNR1POLBHSD17B10
SCHEMBL31702004 0.77 TBXAS1 (0.40) AKR1B1CNR1ALDH1A1KDM4EHSD17B10
SCHEMBL3819996 0.76 AKR1B1 (0.43) AKR1B1ALDH1A1POLBHSD17B10
SCHEMBL29038550 0.75 CNR1 (0.54) CNR1ALDH1A1POLBKDM4ESMN1; SMN2
SCHEMBL29038572 0.75 CNR1 (0.54) CNR1ALDH1A1POLBKDM4ESMN1; SMN2
SCHEMBL27945337 0.75 CNR1 (0.54) CNR1ALDH1A1POLBKDM4ESMN1; SMN2
SCHEMBL31701377 0.75 AKR1B1 (0.37) AKR1B1CNR2POLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009141386-A1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2009-11-26 WO disclosed